Gestational, Post-Delivery Weight Gain Linked to Child's Weight

This article originally appeared here.
Share this content:
Gestational, Post-Delivery Weight Gain Linked to Child's Weight
Gestational, Post-Delivery Weight Gain Linked to Child's Weight

TUESDAY, Oct. 20, 2015 (HealthDay News) -- Maternal gestational weight gain (GWG) and post-delivery weight gain are independently associated with a child's weight development, according to a study published online Oct. 19 in Pediatrics.

Lenie van Rossem, Ph.D., from the University Medical Center Utrecht in the Netherlands, and colleagues used data from 3,367 children participating in a birth cohort starting in 1996 to examine the correlation of GWG and post-delivery weight change with a child's weight development. Data on weight and height were self-reported; GWG was classified as inadequate, adequate, and excessive.

The researchers found that there was higher body mass index (BMI) z score and overweight prevalence throughout childhood for children of mothers with excessive GWG (odds ratio, 1.20; 95 percent confidence interval, 0.99 to 1.46). Compared to children of mothers with a low (<0.5 kg/year) post-delivery weight gain, children of mothers with high (≥1 kg/year) post-delivery weight gain had a 0.14 higher change in BMI z score between age 1 and 14 years. The highest BMI z score and overweight risk at age 14 were seen for children of mothers with excessive GWG in combination with high post-delivery weight gain (odds ratio, 3.53; 95 percent confidence interval, 1.70 to 7.33).

"Maternal GWG and post-delivery weight gain contribute to child's weight development up to adolescence independently," the authors write.

One author disclosed ties to TEVA Pharmaceuticals.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »